Independent Financial Information Made Easy
The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Open: 238.46 Close: 237.82 Change: -0.64
Read more →Open: 243.95 Close: 246.2 Change: 2.25
Read more →Open: 238.88 Close: 239.96 Change: 1.08
Read more →Open: 244.12 Close: 243.0 Change: -1.12
Read more →Open: 240.68 Close: 243.13 Change: 2.45
Read more →Open: 237.1 Close: 237.11 Change: 0.01
Read more →Open: 233.83 Close: 234.65 Change: 0.82
Read more →Open: 254.48 Close: 254.18 Change: -0.3
Read more →Open: 277.19 Close: 277.38 Change: 0.19
Read more →Open: 282.2 Close: 279.97 Change: -2.23
Read more →Open: 256.55 Close: 256.49 Change: -0.06
Read more →Open: 257.38 Close: 258.63 Change: 1.25
Read more →Open: 250.11 Close: 250.76 Change: 0.65
Read more →Open: 263.95 Close: 265.32 Change: 1.37
Read more →Open: 233.36 Close: 235.6 Change: 2.24
Read more →Open: 243.95 Close: 246.2 Change: 2.25
Read more →Open: 242.97 Close: 243.03 Change: 0.06
Read more →Open: 244.12 Close: 243.0 Change: -1.12
Read more →Open: 237.19 Close: 233.68 Change: -3.51
Read more →Open: 233.02 Close: 233.76 Change: 0.74
Read more →Open: 253.0 Close: 251.09 Change: -1.91
Read more →Open: 263.36 Close: 258.53 Change: -4.83
Read more →Open: 277.41 Close: 282.31 Change: 4.9
Read more →Open: 261.8 Close: 261.92 Change: 0.12
Read more →Open: 258.0 Close: 256.55 Change: -1.45
Read more →Open: 250.11 Close: 252.23 Change: 2.12
Read more →Open: 241.58 Close: 241.12 Change: -0.46
Read more →